@FierceMedDev: Roche Dx is slashing jobs as it rethinks its diabetes business. More | Follow @FierceMedDev
@MarkHFierce: Scientists can produce stem cells in great numbers from cadaver scalp tissue. More | Follow @MarkHFierce
@DamianFierce: Japan's Sysmex is in talks to buy Dune Medical Devices for $200M, according to a report. More | Follow @DamianFierce
> NinePoint Medical, a 2012 Fierce 15 winner, is touting new data demonstrating its NvisionVLE imaging system to be more effective than standard biopsy protocol. News
> Medtronic ($MDT) is unveiling a fleet of mobile labs that will trek across the country to educate surgeons on how to use the company's spinal technologies. More
> Spinal Restoration has closed a $5 million financing round, planning to use the money to commercialize its Biostat pain management system. Release
> Here's something to add to the list of stenting benefits: Patients who receive percutaneous coronary intervention report improved sex lives. Story
> CardioDx, another Fierce 15 acolyte, cites a new study showing the company's Corus CAD diagnostic is more cost-effective than imaging for patients who may have coronary artery disease. Item
> ReShape Medical pulled in $15.8 million to commercialize anti-obesity gastric balloon. Article
> Japan's Sysmex snagged 510(k) clearance for its XN series of blood hematology analyzers. News
> Boston Scientific ($BSX) is announcing positive results for its Promus drug-eluting stent among patients with long vascular lesions. More
> Researchers have developed a new adhesive paper that could make for low-cost diagnostics available in the developing world. Story
Biotech News
@FierceBiotech: Hirano bodies may block Alzheimer's-related cell death. More | Follow @FierceBiotech
@JohnCFierce: So AstraZeneca and Ironwood are getting close. AZ pays $25M in cash, up to $125M in miles for China rights to linaclotide; sharing revenue. | Follow @JohnCFierce
@RyanMFierce: e-Therapeutics (computer-enabled network pharmacology) has shelved a MRSA candidate to focus on cancer program. More (reg. req.) | Follow @RyanMFierce
> Abbott doubles down on ADC cancer drugs in $245M-plus Seattle Genetics pact. Report
> GSK taps stem cell discovery to spot heart threats early. Story
> Celgene wraps promising PhIII data on new multiple myeloma challenger. Article
Pharma News
@FiercePharma: EMA says it's investigating Roche for possible shortcomings in pharmacovigilance. More | Follow @FiercePharma
> Eisai snags FDA nod for blockbuster hopeful Fycompa. Story
> Roche to shed 100 jobs in diabetes Dx revamp. Item
> Judge orders FDA to let Watson sell generic Actos. Article
Biotech Research News
> Australian scientists grow HIV antibodies in cow's milk. More
> A transplant anti-rejection treatment could be the next cancer drug. Article
> Pluristem's placental stem cells combat fibrosis in preclinical test. Story
> Scientists produced stem cells from cadaver scalp tissue. Item
Pharma Manufacturing News
> China's WuXi AppTec opens biologics plant. More
> Mexico's Neolpharma snags Pfizer Puerto Rico plant. News
> Mylan buying vertically integrated SMS oncology plant. Story